Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research fostered at RDM has increased the accuracy of echocardiogram interpretations, pinpointing many more people at risk of heart disease.

As part of its artificial intelligence showcase, Oxford University interviews Professor Paul Leeson, who heads the Cardiovascular Clinical Research Facility at RDM.

Professor Leeson is one of the founders of Ultromics, which aims to use artificial intelligence to improve the accuracy of echocardiograms interpretation – echocardiograms are the most widely used imaging test for people with heart disease, but it needs an expert to interpret the images and reach a diagnosis.

When the expert is good, then the test can be very accurate. But because levels of experience vary, this can be difficult to control. - Paul Leeson

But Professor Leeson’s team were able to use machine learning to get accurate clinical interpretations which outstripped human doctors, by combining machine learning and clinical know-how to identify associations between features in the echocardiography images and patient outcomes.

Find out more about how this technique could save lives by identifying more people at risk of heart disease.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

RDM researchers awarded Oxford-Bristol Myers Squibb Fellowships

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Six new Oxford-BMS Fellowships for 2021 were announced.

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.